Konrad Sandhoff
Affiliations: | 1979- | Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Nordrhein-Westfalen, Germany |
Area:
Lipid biochemistryWebsite:
https://www.limes-institut-bonn.de/en/research/research-departments/unit-3/sandhoff-lab/people/lab-head/#c5876Google:
"Konrad Sandhoff"Mean distance: (not calculated yet)
Children
Sign in to add traineeAthanassios Giannis | grad student | 1986 | Universität Bonn |
Christoph Arenz | post-doc | 2001-2004 | Universität Bonn |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Lopergolo D, Berti G, Mari F, et al. (2022) A case of spastic paraplegia type 11 mimicking a GM2-gangliosidosis. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 43: 2849-2852 |
Breiden B, Sandhoff K. (2021) Corrigendum to: Emerging mechanisms of drug-induced phospholipidosis. Biological Chemistry |
Sandhoff K. (2021) Secondary ganglioside GM2 accumulation in mucopolysaccharidoses. Molecular Genetics and Metabolism Reports. 28: 100789 |
Breiden B, Sandhoff K. (2021) Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism. International Journal of Molecular Sciences. 22 |
Breiden B, Sandhoff K. (2020) Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease. International Journal of Molecular Sciences. 21 |
Sen NE, Arsovic A, Meierhofer D, et al. (2019) In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism. International Journal of Molecular Sciences. 20 |
Breiden B, Sandhoff K. (2019) Emerging mechanisms of drug-induced phospholipidosis. Biological Chemistry |
Breiden B, Sandhoff K. (2019) Lysosomal Glycosphingolipid Storage Diseases. Annual Review of Biochemistry. 88: 461-485 |
Anheuser S, Breiden B, Sandhoff K. (2019) Ganglioside GM2 catabolism is inhibited by storage compounds of mucopolysaccharidoses and by cationic amphiphilic drugs. Molecular Genetics and Metabolism |
Anheuser S, Breiden B, Sandhoff K. (2019) Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles. Journal of Lipid Research. 60: 1099-1111 |